AU2014306362B2 - Regeneration of damaged tissue - Google Patents

Regeneration of damaged tissue Download PDF

Info

Publication number
AU2014306362B2
AU2014306362B2 AU2014306362A AU2014306362A AU2014306362B2 AU 2014306362 B2 AU2014306362 B2 AU 2014306362B2 AU 2014306362 A AU2014306362 A AU 2014306362A AU 2014306362 A AU2014306362 A AU 2014306362A AU 2014306362 B2 AU2014306362 B2 AU 2014306362B2
Authority
AU
Australia
Prior art keywords
wound
tropoelastin
tissue
edge
epithelialization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2014306362A
Other languages
English (en)
Other versions
AU2014306362A1 (en
Inventor
Anthony Steven Weiss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Pharmaceuticals International Ltd
Original Assignee
Allergan Pharmaceuticals International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2013903092A external-priority patent/AU2013903092A0/en
Application filed by Allergan Pharmaceuticals International Ltd filed Critical Allergan Pharmaceuticals International Ltd
Priority to AU2014306362A priority Critical patent/AU2014306362B2/en
Publication of AU2014306362A1 publication Critical patent/AU2014306362A1/en
Assigned to ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED reassignment ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED Request for Assignment Assignors: ELASTAGEN PTY LTD
Application granted granted Critical
Publication of AU2014306362B2 publication Critical patent/AU2014306362B2/en
Priority to AU2019204972A priority patent/AU2019204972B2/en
Priority to AU2021245202A priority patent/AU2021245202B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/00051—Accessories for dressings
    • A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A61F13/0203—Adhesive bandages or dressings with fluid retention members
    • A61F13/0213—Adhesive bandages or dressings with fluid retention members the fluid retention member being a layer of hydrocolloid, gel forming material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3633—Extracellular matrix [ECM]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Botany (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
AU2014306362A 2013-08-13 2014-08-13 Regeneration of damaged tissue Active AU2014306362B2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU2014306362A AU2014306362B2 (en) 2013-08-13 2014-08-13 Regeneration of damaged tissue
AU2019204972A AU2019204972B2 (en) 2013-08-13 2019-07-11 Regeneration of damaged tissue
AU2021245202A AU2021245202B2 (en) 2013-08-13 2021-10-08 Regeneration of damaged tissue

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AU2013903092A AU2013903092A0 (en) 2013-08-13 Regeneration of damaged tissue
AU2013903092 2013-08-13
AU2014306362A AU2014306362B2 (en) 2013-08-13 2014-08-13 Regeneration of damaged tissue
PCT/AU2014/050180 WO2015021508A1 (en) 2013-08-13 2014-08-13 Regeneration of damaged tissue

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2019204972A Division AU2019204972B2 (en) 2013-08-13 2019-07-11 Regeneration of damaged tissue

Publications (2)

Publication Number Publication Date
AU2014306362A1 AU2014306362A1 (en) 2016-02-18
AU2014306362B2 true AU2014306362B2 (en) 2019-04-18

Family

ID=52467858

Family Applications (3)

Application Number Title Priority Date Filing Date
AU2014306362A Active AU2014306362B2 (en) 2013-08-13 2014-08-13 Regeneration of damaged tissue
AU2019204972A Active AU2019204972B2 (en) 2013-08-13 2019-07-11 Regeneration of damaged tissue
AU2021245202A Active AU2021245202B2 (en) 2013-08-13 2021-10-08 Regeneration of damaged tissue

Family Applications After (2)

Application Number Title Priority Date Filing Date
AU2019204972A Active AU2019204972B2 (en) 2013-08-13 2019-07-11 Regeneration of damaged tissue
AU2021245202A Active AU2021245202B2 (en) 2013-08-13 2021-10-08 Regeneration of damaged tissue

Country Status (12)

Country Link
US (4) US20160194379A1 (enExample)
EP (2) EP4316537A3 (enExample)
JP (3) JP6382311B2 (enExample)
KR (3) KR102488446B1 (enExample)
CN (2) CN110464837A (enExample)
AU (3) AU2014306362B2 (enExample)
BR (1) BR112016003082A8 (enExample)
CA (1) CA2920312C (enExample)
ES (1) ES2965893T3 (enExample)
MX (2) MX377200B (enExample)
RU (1) RU2677637C2 (enExample)
WO (1) WO2015021508A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9688741B2 (en) 2012-10-23 2017-06-27 Elastagen Pty Ltd Elastic hydrogel
ES2702602T3 (es) 2012-12-10 2019-03-04 Allergan Pharmaceuticals Int Ltd Fabricación de construcciones tridimensionales elásticas escalables
EP4316537A3 (en) 2013-08-13 2024-04-10 Allergan Pharmaceuticals International Limited Regeneration of damaged tissue
AU2016314775A1 (en) * 2015-09-01 2018-03-22 Allergan Pharmaceuticals International Limited Formation of bone
CN110121369A (zh) * 2016-11-04 2019-08-13 艾尔建制药国际有限公司 生物合成装置
CA3136074A1 (en) * 2019-05-03 2020-11-12 Robert Daniels Scar prevention and/or treatment
US20230310552A1 (en) * 2020-09-08 2023-10-05 Protein Genomics Inc. Biomimetic wound healing devices and related methods of treating diabetic wounds

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994014958A1 (en) * 1992-12-22 1994-07-07 The University Of Sydney Synthetic polynucleotides
WO2000073399A1 (en) * 1999-05-28 2000-12-07 Providence Health System-Oregon Methods for producing laminated elastin, elastin-based materials and tropoelastin products for repairing and/or replacing tissue
WO2001056595A2 (en) * 2000-02-04 2001-08-09 Ensley Burt D Wound healing compositions and methods using tropoelastin and lysyl oxidase
WO2008058323A1 (en) * 2006-11-13 2008-05-22 The University Of Sydney Use of tropoelastin for repair or restoration of tissue
WO2009015372A1 (en) * 2007-07-25 2009-01-29 Dermaplus, Inc. Photo-protective dermatological formulations and methods of using the same
WO2013044314A1 (en) * 2011-09-30 2013-04-04 The University Of Sydney In vivo synthesis of elastic fiber
WO2014063194A1 (en) * 2012-10-23 2014-05-01 The University Of Sydney Elastic hydrogel

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675387A (en) 1985-07-26 1987-06-23 E. I. Du Pont De Nemours And Company Method for extracting protein with organic acid
US5260203A (en) 1986-09-02 1993-11-09 Enzon, Inc. Single polypeptide chain binding molecules
US4947840A (en) 1987-08-21 1990-08-14 Massachusetts Institute Of Technology Biodegradable templates for the regeneration of tissues
ATE102631T1 (de) 1988-11-11 1994-03-15 Medical Res Council Klonierung von immunglobulin sequenzen aus den variabelen domaenen.
CA2057014C (en) 1990-03-30 2001-07-24 Toshihiko Kaminuma Process for purification of polypeptide
WO1994007921A1 (en) 1992-09-25 1994-04-14 Commonwealth Scientific And Industrial Research Organisation Target binding polypeptide
US5726040A (en) 1993-11-10 1998-03-10 Ensley; Burt D. Cosmetic compositions including tropoelastin isomorphs
US7001328B1 (en) * 1994-11-15 2006-02-21 Kenton W. Gregory Method for using tropoelastin and for producing tropoelastin biomaterials
AUPO591797A0 (en) 1997-03-27 1997-04-24 Commonwealth Scientific And Industrial Research Organisation High avidity polyvalent and polyspecific reagents
EP0922058A2 (en) 1996-08-07 1999-06-16 Protein Specialities Ltd. Self-aligning peptides derived from elastin and other fibrous proteins
AUPO156596A0 (en) * 1996-08-09 1996-09-05 University Of Sydney, The Synthetic polynucleotides
CA2279902C (en) 1997-02-07 2009-01-13 Sisters Of Providence In Oregon Method for using tropoelastin and for producing tropoelastin biomaterials
AUPO811797A0 (en) 1997-07-18 1997-08-14 University Of Sydney, The Tropoelastin derivatives
WO1999011196A1 (en) 1997-09-04 1999-03-11 Point Biomedical Corporation Injectable tissue reconstruction material
AUPP472398A0 (en) 1998-07-17 1998-08-13 University Of Sydney, The Protease susceptibility II
US7109292B2 (en) 1999-03-08 2006-09-19 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
DK1229940T3 (da) 1999-11-15 2014-08-18 Piramal Healthcare Canada Ltd Temperaturstyret og ph-afhængig selvgelerende, vandig biopolymeropløsning
US20050244393A1 (en) 1999-12-22 2005-11-03 Henogen S.A. Sealant or tissue generating product
US20040110439A1 (en) 2001-04-20 2004-06-10 Chaikof Elliot L Native protein mimetic fibers, fiber networks and fabrics for medical use
WO2002096978A1 (en) 2001-05-30 2002-12-05 Keiichi Miyamoto Crosslinked elastin and process for producing the same
AU2002952492A0 (en) 2002-11-06 2002-11-21 Cbio Limited Chaperonin 10 immunosuppression
US8383158B2 (en) 2003-04-15 2013-02-26 Abbott Cardiovascular Systems Inc. Methods and compositions to treat myocardial conditions
US8038991B1 (en) 2003-04-15 2011-10-18 Abbott Cardiovascular Systems Inc. High-viscosity hyaluronic acid compositions to treat myocardial conditions
FR2855969B1 (fr) 2003-06-13 2012-11-30 Coletica Stimulation de l'activite d'une isoforme de lysyl oxydase pour lutter contre certaines pathologies dues a une elastogenese incomplete, absente ou desorganisee
FR2855968B1 (fr) 2003-06-13 2012-11-30 Coletica Stimulation de la synthese et de l'activite d'une isoforme de la lysyl oxydase-like loxl pour stimuler la formation de fibres elastiques
US8226715B2 (en) 2003-06-30 2012-07-24 Depuy Mitek, Inc. Scaffold for connective tissue repair
CA2846382C (en) 2004-02-20 2017-09-19 The Hospital For Sick Children Manganese based compounds for elastogenesis and connective tissue treatment
US7192043B1 (en) 2004-05-25 2007-03-20 Mcluen Design, Inc. Multi-terrain wheel chair
US7968085B2 (en) 2004-07-05 2011-06-28 Ascendis Pharma A/S Hydrogel formulations
US20060062768A1 (en) 2004-09-23 2006-03-23 Olexander Hnojewyj Biocompatible hydrogel compositions
WO2006098024A1 (ja) 2005-03-16 2006-09-21 Fujitsu Limited Ipネットワークにおけるマルチキャストツリー監視方法およびシステム
CA2602947A1 (en) 2005-03-24 2006-09-28 Straumann Holding Ag Method for protein purification comprising heat incubation in acetic acidic solution
US8828433B2 (en) 2005-04-19 2014-09-09 Advanced Cardiovascular Systems, Inc. Hydrogel bioscaffoldings and biomedical device coatings
KR100785378B1 (ko) 2005-09-05 2007-12-14 주식회사 바이오레인 다층구조의 유착방지제
US20090169593A1 (en) 2005-10-19 2009-07-02 Biomedical Research Services, Inc. Method of using and producing tropoelastin and tropoelastin biomaterials
US7770126B2 (en) 2006-02-10 2010-08-03 Microsoft Corporation Assisting user interface element use
US8518105B2 (en) 2006-03-24 2013-08-27 Abbott Cardiovascular System Inc. Methods and apparatuses for coating a lesion
US20070237735A1 (en) 2006-03-31 2007-10-11 Laboratoires Dermo-Cosmetik Inc. Anti-aging composition, kit and method of use
AU2007285483B2 (en) 2006-05-11 2011-12-22 Regenics As Administration of cells and cellular extracts for rejuvenation
US20070287741A1 (en) 2006-06-13 2007-12-13 Uri Herzberg Compositions and methods for preventing or reducing postoperative ileus and gastric stasis in mammals
WO2008033847A2 (en) 2006-09-11 2008-03-20 Emory University Modified protein polymers
US7700126B2 (en) 2006-09-29 2010-04-20 Martin Kean Chong Ng Tropoelastin-based protoelastin biomaterials
WO2009018546A1 (en) 2007-08-02 2009-02-05 Medicis Pharmaceutical Corporation Method of applying an injectable filler
FR2920968B1 (fr) 2007-09-14 2009-11-13 Oreal Procede cosmetique de traitement esthetique et/ou reparateur de la peau
US9421305B2 (en) 2008-02-01 2016-08-23 Wake Forest University Health Sciences Aligned scaffolding system for skeletal muscle regeneration
US8469961B2 (en) 2008-03-05 2013-06-25 Neville Alleyne Methods and compositions for minimally invasive capsular augmentation of canine coxofemoral joints
US8940331B2 (en) 2008-11-22 2015-01-27 The Board Of Trustees Of The Leland Stanford Junior University Hydrogels, methods of making hydrogels, methods of using hydrogels, and methods of isolating, trapping, attracting, and/or killing cancer cells
US8080265B2 (en) 2009-02-20 2011-12-20 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating signs of skin aging
EP3881825B1 (en) * 2009-03-10 2024-12-25 Allergan Pharmaceuticals International Limited Injectable biomaterials
PL2550027T5 (pl) 2010-03-22 2019-07-31 Allergan, Inc. Polisacharydowe i białkowo-polisacharydowe usieciowane hydrożele do powiększania tkanek miękkich
WO2011127478A1 (en) 2010-04-09 2011-10-13 Nanovasc, Inc. Sleeve for graft and method
US8658711B2 (en) 2010-09-29 2014-02-25 Rutgers, The State University Of New Jersey Process for the synthesis of methacrylate-derivatized type-1 collagen and derivatives thereof
EP4043043A1 (en) 2010-11-23 2022-08-17 Allergan Pharmaceuticals International Limited Preparation and/or formulation of proteins cross-linked with polysaccharides
GB201021438D0 (en) 2010-12-16 2011-02-02 Imp Innovations Ltd Layered fibrous construct
US9114128B2 (en) * 2011-09-30 2015-08-25 Protein Genomics, Inc. Tropoelastins and uses thereof
ES2702602T3 (es) 2012-12-10 2019-03-04 Allergan Pharmaceuticals Int Ltd Fabricación de construcciones tridimensionales elásticas escalables
EP4316537A3 (en) * 2013-08-13 2024-04-10 Allergan Pharmaceuticals International Limited Regeneration of damaged tissue
KR20200138836A (ko) 2013-09-24 2020-12-10 앨러간 파마슈티컬스 인터내셔널 리미티드 단백질 추출 방법

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994014958A1 (en) * 1992-12-22 1994-07-07 The University Of Sydney Synthetic polynucleotides
WO2000073399A1 (en) * 1999-05-28 2000-12-07 Providence Health System-Oregon Methods for producing laminated elastin, elastin-based materials and tropoelastin products for repairing and/or replacing tissue
WO2001056595A2 (en) * 2000-02-04 2001-08-09 Ensley Burt D Wound healing compositions and methods using tropoelastin and lysyl oxidase
WO2008058323A1 (en) * 2006-11-13 2008-05-22 The University Of Sydney Use of tropoelastin for repair or restoration of tissue
WO2009015372A1 (en) * 2007-07-25 2009-01-29 Dermaplus, Inc. Photo-protective dermatological formulations and methods of using the same
WO2013044314A1 (en) * 2011-09-30 2013-04-04 The University Of Sydney In vivo synthesis of elastic fiber
WO2014063194A1 (en) * 2012-10-23 2014-05-01 The University Of Sydney Elastic hydrogel

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
KELLOUCHE, S. et al. "Tissue engineering for full-thickness burns: a dermal substitute from bench to bedside." Biochemical and Biophysical Research Communications, 2007 Nov 23;363(3):472-8. Epub 2007 Sep 4. *
RNJAK, J. et al. "Severe bum injuries and the role of elastin in the design of de1mal substitutes." Tissue Engineering: Part B Rev. 2011 Apr;l 7(2):81-91. Epub 2011 Feb 3. Review *
WISE, S.G. et al. "Engineered tropoelastin and elastin-based biomaterials." Advances in Protein and Chemical Structural Biology. 2009;78:1-24. Epub 2009 Nov 27. *

Also Published As

Publication number Publication date
WO2015021508A1 (en) 2015-02-19
JP6639587B2 (ja) 2020-02-05
RU2677637C2 (ru) 2019-01-18
BR112016003082A8 (pt) 2020-01-28
RU2016104618A3 (enExample) 2018-06-18
US20220098281A1 (en) 2022-03-31
AU2019204972A1 (en) 2019-08-01
CN105530951B (zh) 2019-10-22
MX2016001436A (es) 2016-07-05
US20250171522A1 (en) 2025-05-29
AU2021245202A1 (en) 2021-11-04
US20190062405A1 (en) 2019-02-28
JP6891257B2 (ja) 2021-06-18
AU2021245202B2 (en) 2025-01-23
KR20210154881A (ko) 2021-12-21
CN110464837A (zh) 2019-11-19
JP2020049282A (ja) 2020-04-02
CA2920312A1 (en) 2015-02-19
US20160194379A1 (en) 2016-07-07
MX2020011880A (es) 2021-01-20
KR102488446B1 (ko) 2023-01-13
MX377200B (es) 2025-03-07
KR20160041949A (ko) 2016-04-18
AU2019204972B2 (en) 2021-07-08
EP4316537A3 (en) 2024-04-10
KR20230004965A (ko) 2023-01-06
EP3033099B1 (en) 2023-11-01
RU2016104618A (ru) 2017-09-14
EP3033099A1 (en) 2016-06-22
CA2920312C (en) 2022-07-19
BR112016003082A2 (pt) 2017-08-01
EP4316537A2 (en) 2024-02-07
JP2016527979A (ja) 2016-09-15
JP2018164789A (ja) 2018-10-25
AU2014306362A1 (en) 2016-02-18
CN105530951A (zh) 2016-04-27
ES2965893T3 (es) 2024-04-17
EP3033099A4 (en) 2017-04-12
US11084867B2 (en) 2021-08-10
JP6382311B2 (ja) 2018-08-29

Similar Documents

Publication Publication Date Title
AU2021245202B2 (en) Regeneration of damaged tissue
Lagus et al. Prospective study on burns treated with Integra®, a cellulose sponge and split thickness skin graft: comparative clinical and histological study—randomized controlled trial
JP7303612B2 (ja) 熱傷の進行の緩和ならびに皮膚移植片の取り込みおよび治癒の改善における再生細胞の使用
Haifei et al. The effect of collagen–chitosan porous scaffold thickness on dermal regeneration in a one-stage grafting procedure
CN102137926A (zh) 促进由成纤维细胞生成ecm和/或促进生物体系中成纤维细胞迁移
US20240293596A1 (en) Compositions and methods for treating wounds
US20240115764A1 (en) Collagen compositions and uses for biomaterial implants
HK40016252A (zh) 受损组织的再生
JP7691565B1 (ja) 生体組織の瘢痕化を抑制するための創傷用足場材
최진일 Assessment of Wound Healing Efficacy of Porcine Placental Amniotic Membrane Derived Extracellular Matrix
Xie Ex vivo investigation of novel wound healing therapies and development of a 3-D human skin equivalent wound model
Nath A Clinical Study on the Efficacy of Autologous Platelet Rich Plasma in the Management of Chronic Non Healing Ulcers
Charles et al. 19 Active Treatments for Acute and Chronic Wounds

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED

Free format text: FORMER APPLICANT(S): ELASTAGEN PTY LTD

FGA Letters patent sealed or granted (standard patent)